Dietary supplementations of amino acids: Evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 3, 2009, Pages 139-145

  Batool, Farhat ^a,c   Ahmed, Shoaib ^b   Haleem, Darakhshan Jabeen ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b Malir National University of Medical Sciences   (Pakistan)

^c NONE   (Pakistan)

Author keywords

Amino acids supplementations; Catalepsy; Haloperidol; mPFC serotonin; Schizophrenia; Trp LNAA ratio

Indexed keywords

AMINO ACID; DRINKING WATER; HALOPERIDOL; SEROTONIN; SODIUM CHLORIDE; TRYPTOPHAN; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG WITHDRAWAL; ELECTROCHEMICAL DETECTION; EXPLORATORY BEHAVIOR; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; RAT; SEROTONIN METABOLISM; SEROTONINERGIC TRANSMISSION;

EID: 64149090605     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Van der Heijden FM, Fekkes D, Tuinier S, Sijben AE, Kahn RS, Verhoeyen WM. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics. J Neural Transm 2005; 112:577-85.
2. Sandyk R, Barford CR, Khan I. L-tryptophan in neuroleptic-induced tardive dyskinesia. Int J Neurosci 1998; 42:127-30.
3. Haleem DJ. Injected tryptophan increases brain but not plasma tryptophan levels more in ethanol treated rats. Life Sci 1990; 47: 971-9.
4. 1A receptor agonism in the expression of behavioural dopaminergic supersensitivity in subchronic haloperidol treated rats. Pak J Pharm Sci 2008; 21: 411-20.
5. Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS. Dopamine/ serotonin metabolite ratio and extrapyramidal effects of clozapine in rats. J Coll Physicians Surg Pak 2002; 12:588-92.
6. Haleem DJ, Saify ZS, Siddiqui S, Batool F, Haleem MA. Pre- and postsynaptic responses to 1-(1-naphthylpiperazine) following adaptation to stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:149-56.
7. Richardson MA, Margaret LB, Josephine BW, Janet JG. Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology (Berl) 2004; 143:358-64.
8. Samad N, Batool F, Haleem DJ. Neurochemical and behavioural effects of 8-OH-DPAT following exposure to restraint stress in rats. Pharmacol Rep 2007; 59:173-80.
9. 2) receptors in the rat brain. Brain Res 1989; 487:288-98.
10. Balsara JJ, Jadhav JH, Chandokar AG. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology (Berl) 1979; 62:67-9.
11. Vidali M, Fregnan GB. Effects of different CNS-active drugs on the catalepsy induced by neuroleptics. Curr Ther Res 1979; 25: 544-56.
12. Wadenberg ML. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 1996; 20: 325-39.
13. 2A receptors. Neuropharmacology 2004; 47:527-37.
14. 1A receptors, schizophrenia and antipsychotic agents. Int J Neurqpgchopharmacol 2000; 3:S13. Abstract S.09.1.
15. Batool F, Siddiqui S, Haleem DJ. Neurochemical and behavioural profiles of 1-(1-Naphthyl) piperazine in rats. J Coll Physicians Surg Pak 2001; 11:50-6.
16. Batool F, Haleem DJ, Saify ZS, Haleem MA. Neurochemical and extra pyramidal effects of atypical neuroleptic clozapine in rats. Pak J Pharm Sci 2000; 13: 47-55.
17. Buckman RW, Malan RD. Clozapine for refractory schizophrenia: the Illinois experience. J Clin Psychiatry 1990; 60: 18-22.
18. Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999; 21:106S-115S.
19. Meltzer HY. Clinical studies on the mechanism of action of clozapine-the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 1989; 99:S18-S27.
20. Gibson MD, Tandon R. A summary of new research findings on the new antipsychotic drugs. Ess Psychopharmacol 1997; 1:27-37.
21. Sandyk R, Fisher H. Serotonin in involuntary movement disorders. Int J Neurosci 1988; 42:185-208.
22. 1A receptor agonism on antipsychotic drug-induced cloparnine release in rat striatum and nucleus accumbens. Brain Res 2000; 858:252-63.
23. Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS, et al. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and tests related to extrapyramidal functions in rats. Med Sci Monit 2002; 8:BR354-61.
24. 1A agonist properties. Neuropsychopharmacology 2006; 31:1869-79.
25. 2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. Brain Res 2002; 947: 157-65.